The role of AHR-inducible cytochrome P450s in metabolism of polyunsaturated fatty acids

Drug Metabolism Reviews

Volumn 48, Issue 3, 2016, Pages 342-350

  Hankinson, Oliver ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

2,3,7,8 Tetrachlorodibenzo dioxin (TCDD); aryl hydrocarbon receptor (AHR); CYP1; eicosanoid; metastasis; omega 3 ( 3) PUFA; omega 6 ( 6) PUFA; oxylipin; polyunsaturated fatty acids (PUFA); tumor growth

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450; DIOL; EPOXIDE; HYDROXYL GROUP; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OXYLIPIN; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG; CYTOCHROME P450 INDUCER; POLYCHLORINATED DIBENZODIOXIN; UNSATURATED FATTY ACID;

ANGIOGENESIS; BIOLOGICAL ACTIVITY; CARCINOGENESIS; DIET; HUMAN; LIVER; LUNG; METABOLISM; METABOLITE; METASTASIS; MOLECULAR BIOLOGY; NONHUMAN; POLLUTANT; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; TISSUE DISTRIBUTION; TUMOR CELL; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS;

ANIMALS; CYTOCHROME P-450 ENZYME INDUCERS; CYTOCHROME P-450 ENZYME SYSTEM; FATTY ACIDS, UNSATURATED; HUMANS; POLYCHLORINATED DIBENZODIOXINS; RECEPTORS, ARYL HYDROCARBON;

EID: 84984972083     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.1080/03602532.2016.1197240     Document Type: Review

References (40)

1. J.Abel, W.Li, O.D ṏõhr. (1996). Dose-response relationship of cytochrome P4501b1 mRNA induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in livers of C57BL/6J and DBA/2J mice. Arch Toxicol 70:510–513.
2. V.P.Androutsopoulos, A.M.Tsatsakis, D.A.Spandidos (2009). Cytochrome P450 CYP1A1:Wider roles in cancer progression and prevention. BMC Cancer 9:187.
3. A.Bessede, M.Gargaro, M.Pallotta. (2014). Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511:184–190.
4. P.C.Boutros, R.Yan, I.D.Moffatt. (2008). Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver:comparison of rat and mouse. BMC Genomics 9:419.
5. M.W.Buczynski, D.S.Dumlao, E.A.Dennis (2009). Thematic review series:Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res 50:1015–1038.
6. P.Bui, P.Solaimani, X.Wu. (2012). 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion. Toxicol Appl Pharmacol 259:143–151.
7. D.Choudhary, I.Jansson, I.Stoilov. (2004). Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab Dispos 32:840–847.
8. T.P.Dalton, J.K.Kerzee, B.Wang. (2001). Dioxin exposure is an environmental risk factor for ischemic heart disease. Cardiovasc Toxicol 1:285–298.
9. M.S.Denison, A.A.Soshilov, G.He. (2011). Exactly the same but different:Promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci 124:1–22.
10. S.Diani-Moore, Y.Ma, S.S.Gross. (2014). Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA. Drug Metabol Dispos 42:294–300.
11. S.Feng, Z.Cao, X.Wang (2013). Role of aryl hydrocarbon receptor in cancer. Biochim Biophys Acta 1836:197–210.
12. M.Fer, Y.Dreano, D.Lucas. (2008). Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450. Arch Biochem Biophys 471:116–125.
13. R.J.Fontana, K.S.Lown, M.F.Paine. (1999). Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology 117:89–98.
14. A.L.Forgacs, M.N.Kent, M.K.Makley. (2012). Comparative metabolomic and genomic analyses of TCDD-elicited metabolic disruption in mouse and rat liver. Toxicol Sci 125:41–55.
15. T.A.Gasiewicz, E.C.Henry (2011). History of research on the AHR. In:R.Pohjanvirta, ed. The AH receptor in biology and toxicology. Hoboken (NJ):Wiley, 3–32.
16. O.Hankinson (1995). The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307–340.
17. O.Hankinson (2012) The AHR/ARNT dimer and transcriptional coactivators. In R.Pohjanvirta, ed. The AH receptor in biology and toxicology. Hoboken (NJ):John Wiley & Sons, Inc. 93–100.
18. P.A.Harper, D.S.Riddick, A.B.Okey (2006). Regulating the regulator:Factors that control levels and activity of the aryl hydrocarbon receptor. Biochem Pharmacol 72:267–279.
19. K.R.Hayes, G.M.Zastrow, M.Nukaya. (2007). Hepatic transcriptional networks induced by exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chem Res Toxicol 20:1573–1581.
20. J.G.Jiang, Y.G.Ning, C.Chen. (2007). Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res 67:6665–6674.
21. M.Kinehara, I.Fukuda, K.Yoshida, H.Ashida. (2009). Aryl hydrocarbon receptor-mediated induction of the cytosolic phospholase A(2)alpha gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse hepatoma Hepa-1c1c7 cells. J Biosci Bioeng 108:277–281.
22. Y.Kita, T.Ohto, N.Uozumi, T.Shimizu. (2006). Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s. Biochimica Et Biophysica Acta 1761:1317–1322.
23. A.K.Kopec, L.D.Burgoon, D.Ibrahim-Aibo. (2010). Automated dose-response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF, and PCB126 in C57BL/6 mice. Toxicol Sci 118:286–297.
24. A.K.Kopec, M.L.D’Souza, B.D.Mets. (2011). Non-additive hepatic gene expression elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) co-treatment in C57BL/6 mice. Toxicol Appl Pharmacol 256:154–167.
25. S.Lin, Z.Yang, H.Liu, Z.Cai (2011). Metabolomic analysis of liver and skeletal muscle tissues in C57BL/6J and DBA/2J mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Biosyst 7:1956–1965.
26. P.Moura-Alves, K.Fae, E.Houthuys. (2014). AhR sensing of bacterial pigments regulates antibacterial defence. Nature 512:387–392.
27. S.Norwood, J.Liao, B.D.Hammock. (2010). Epoxyeicosatrienoic acids and soluble epoxide hydrolase:Potential therapeutic targets for inflammation and its induced carcinogenesis. Am J Transl Res 2:447–457.
28. C.A.Opitz, U.M.Litzenburger, F.Sahm. (2011). An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478:197–203.
29. D.Panigrahy, M.L.Edin, C.R.Lee. (2012). Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Invest 122:178–191.
30. A.Pozzi, M.R.Ibanez, A.E.Gatica. (2007). Peroxisomal proliferator-activated receptor-alpha-dependent inhibition of endothelial cell proliferation and tumorigenesis. J Biol Chem 282:17685–17695.
31. A.Pozzi, V.Popescu, S.Yang. (2010). The anti-tumorigenic properties of peroxisomal proliferator-activated receptor alpha are arachidonic acid epoxygenase-mediated. J Biol Chem 285:12840–12850.
32. A.B.Rifkind (2006). CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates. Drug Metab Rev 38:291–335.
33. J.J.Schlezinger, C.Parker, D.C.Zeldin, J.J.Stegeman. (1998). Arachidonic acid metabolism in the marine fish Stenotomus chrysops (Scup) and the effects of cytochrome P450 1A inducers. Arch Biochem Biophys 353:265–275.
34. D.Schwarz, P.Kisselev, S.S.Ericksen. (2004). Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1:Highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. Biochem Pharmacol 67:1445–1457.
35. 540 epoxygenase pathway of polyunsaturated fatty acid metabolism. Biochimica Biophysica Acta 1851:356–365.
36. L.Stejskalova, P.Pavek (2011). The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta. Curr Pharm Biotechnol 12:715–730.
37. C.Vogel, U.S.Schuhmacher. G.H.Degen. (1998). Modulation of prostaglandin H Synthase-2 mRNA expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice. Arch Biochem Biophys 352:265–271.
38. J.Yang, P.Solaimani, H.Dong. (2013). Treatment of mice with 2,3,7,8-Tetrachlorodibenzo-p-dioxin markedly increases the levels of a number of cytochrome P450 metabolites of omega-3 polyunsaturated fatty acids in the liver and lung. J Toxicol Sci 38:833–836.
39. G.Zhang, D.Panigraphy, L.M.Mahakian. (2013). Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci USA 110:6530–6535.
40. G.Zhang, D.Panigraphy, S.H.Hwang. (2014). Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis. Proc Natl Acad Sci USA 111:11127–11132. PMCID:PMC4121808.